A citation-based method for searching scientific literature

Gillian S Dite, Robert J MacInnis, Adrian Bickerstaffe, James G Dowty, Richard Allman, Carmel Apicella, Roger L Milne, Helen Tsimiklis, Kelly-Anne Phillips, Graham G Giles, Mary Beth Terry, Melissa C Southey, John L Hopper. Cancer Epidemiol Biomarkers Prev 2016
Times Cited: 62



Hongyan Li, Bingjian Feng, Alexander Miron, Xiaoqing Chen, Jonathan Beesley, Emmanuella Bimeh, Daniel Barrowdale, Esther M John, Mary B Daly, Irene L Andrulis, Saundra S Buys, Peter Kraft, Heather Thorne, Georgia Chenevix-Trench, Melissa C Southey, Antonis C Antoniou, Paul A James, Mary Beth Terry, Kelly-Anne Phillips, John L Hopper, Gillian Mitchell, David E Goldgar. Genet Med 2017
Times Cited: 28




List of shared articles



Times cited

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.
Taru A Muranen, Nasim Mavaddat, Sofia Khan, Rainer Fagerholm, Liisa Pelttari, Andrew Lee, Kristiina Aittomäki, Carl Blomqvist, Douglas F Easton, Heli Nevanlinna. Breast Cancer Res Treat 2016
13

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Celine M Vachon, Christopher G Scott, Rulla M Tamimi, Deborah J Thompson, Peter A Fasching, Jennifer Stone, Melissa C Southey, Stacey Winham, Sara Lindström, Jenna Lilyquist,[...]. Breast Cancer Res 2019
12

The emerging field of polygenic risk scores and perspective for use in clinical care.
Tatiane Yanes, Aideen M McInerney-Leo, Matthew H Law, Shelly Cummings. Hum Mol Genet 2020
7

Towards a more precise and individualized assessment of breast cancer risk.
Marie E Wood, Nicholas H Farina, Thomas P Ahern, Melissa E Cuke, Janet L Stein, Gary S Stein, Jane B Lian. Aging (Albany NY) 2019
8

Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
Ava Willoughby, Paul R Andreassen, Amanda Ewart Toland. J Pers Med 2019
13

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families.
Inge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, Andrew Lee, Maaike P G Vreeswijk, Antoinette Hollestelle, Caroline Seynaeve, Hanne Meijers-Heijboer, Jan C Oosterwijk, Nicoline Hoogerbrugge,[...]. J Med Genet 2019
14

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
25

Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk.
Rajneesh Kaur, Bettina Meiser, Tatiane Yanes, Mary-Anne Young, Kristine Barlow-Stewart, Tony Roscioli, Sian Smith, Paul A James. Fam Cancer 2019
5

Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.
Tatiane Yanes, Bettina Meiser, Mary-Anne Young, Rajneesh Kaur, Gillian Mitchell, Kristine Barlow-Stewart, Tony Roscioli, Jane Halliday, Paul James. BMC Cancer 2017
9